Ca2+-independent activation of the endothelial nitric oxide synthase in response to tyrosine phosphatase inhibitors and fluid shear stress

Circulation Research
I FlemingR Busse

Abstract

Fluid shear stress enhances NO formation via a Ca2+-independent tyrosine kinase inhibitor-sensitive pathway. In the present study, we investigated the effects of the protein tyrosine phosphatase inhibitor phenylarsine oxide and of fluid shear stress on endothelial NO production as well as on the membrane association and phosphorylation of the NO synthase (NOS) III. Phenylarsine oxide (10 micromol/L) induced an immediate and maintained NO-mediated relaxation of isolated rabbit carotid arteries, which was insensitive to the removal of extracellular Ca2+ and the calmodulin antagonist calmidazolium. This phenylarsine oxide-induced vasodilatation was unaffected by genistein but abrogated by the tyrosine kinase inhibitor erbstatin A. Incubation of native or cultured endothelial cells with phenylarsine oxide resulted in a time-dependent tyrosine phosphorylation of mainly Triton X-100-insoluble (cytoskeletal) proteins, along with a parallel change in the detergent solubility of NOS III, such that the enzyme was recovered in the cytoskeletal fraction. A similar, though slightly delayed, phenomenon was also observed after the application of fluid shear stress but not in response to any receptor-dependent agonist. Although Ca2+-independen...Continue Reading

Associated Clinical Trials

References

Jul 1, 1992·Pflügers Archiv : European journal of physiology·G SchwarzB Nilius
Feb 11, 1992·The American Journal of Physiology·J ShenM A Gimbrone
Dec 1, 1989·Naunyn-Schmiedeberg's Archives of Pharmacology·A MülschR Busse
Jan 1, 1983·Methods in Enzymology·J A CooperT Hunter
Oct 24, 1995·Proceedings of the National Academy of Sciences of the United States of America·E J SmartR G Anderson
Jan 20, 1995·The Journal of Biological Chemistry·L J RobinsonT Michel
Jun 1, 1995·Annals of Medicine·R Busse, I Fleming
Jul 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·T MichelL Busconi
Aug 15, 1994·Biochemical and Biophysical Research Communications·H J KruseW Siess
Mar 1, 1994·The American Journal of Physiology·M J Kuchan, J A Frangos
Mar 15, 1996·The Journal of Biological Chemistry·P W ShaulT Michel
Aug 1, 1996·The Journal of Experimental Medicine·D S ChaoD S Bredt
Nov 1, 1996·The Journal of Biological Chemistry·G García-CardeñaW C Sessa
Jun 20, 1997·The Journal of Biological Chemistry·J B MichelT Michel
Jul 9, 1997·Biochemical and Biophysical Research Communications·V J VenemaR C Venema

❮ Previous
Next ❯

Citations

Mar 4, 2000·Medical & Biological Engineering & Computing·S MochizukiF Kajiya
Jun 1, 2006·Naunyn-Schmiedeberg's Archives of Pharmacology·Dhvanit I Shah, Manjeet Singh
Dec 17, 2009·Pflügers Archiv : European journal of physiology·Ingrid Fleming
Feb 18, 2006·Cell and Tissue Research·Dimitri Scholz, Wolfgang Schaper
Dec 5, 2008·Molecular and Cellular Biochemistry·R I VijiP R Sudhakaran
Aug 7, 2012·Molecular and Cellular Biochemistry·Israel Ramirez-SanchezFrancisco Villarreal
Sep 12, 2000·Current Hypertension Reports·R Busse, I Fleming
Mar 3, 2005·Nitric Oxide : Biology and Chemistry·Sofia MariottoHisanori Suzuki
Jan 17, 2004·The Annals of Thoracic Surgery·Ayako MaruoHartzell V Schaff
Jul 9, 2003·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·G Cirino
Mar 5, 2002·British Journal of Clinical Pharmacology·Dilly O C AnumbaGary A Ford
Feb 26, 2000·Acta Physiologica Scandinavica·B FisslthalerI Fleming
Feb 5, 2002·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Hirofumi KawanakaAndrzej S Tarnawski
Feb 3, 1999·Proceedings of the National Academy of Sciences of the United States of America·I FlemingR Busse
Jan 28, 2004·The Journal of Experimental Medicine·Voahanginirina RandriamboavonjyIngrid Fleming
Sep 30, 2008·Antioxidants & Redox Signaling·Ravi NistalaJames R Sowers
Sep 22, 2010·Antioxidants & Redox Signaling·Joji Ando, Kimiko Yamamoto
Jan 23, 1999·Current Opinion in Nephrology and Hypertension·O Feron
Jun 12, 2004·Clinical and Experimental Pharmacology & Physiology·C DevauxC Thuillez
Jan 7, 2011·American Journal of Physiology. Cell Physiology·Israel Ramirez-SanchezFrancisco Villarreal
Jan 2, 2009·American Journal of Physiology. Lung Cellular and Molecular Physiology·Neetu SudStephen M Black
May 23, 2007·Mediators of Inflammation·Eudoxia KitsiopoulouPaschalis-Adam Molyvdas
Nov 17, 2004·Thrombosis Journal·Robert H Williams, Matthias U Nollert
Mar 13, 2008·Environmental Health Perspectives·Alpa P ShahMark W Frampton
Sep 6, 2007·PloS One·Veronika HartmannsgruberRalf Köhler
Feb 8, 2011·PloS One·Caterina MammiDavide Lauro
Apr 6, 2006·Clinical Medicine & Research·Zhihong Yang, Xiu-Fen Ming
Dec 4, 2013·Antioxidants & Redox Signaling·Jennifer K BendallMark J Crabtree
Oct 27, 1999·Proceedings of the National Academy of Sciences of the United States of America·J IgarashiT Michel
Feb 24, 2001·Comptes rendus de l'Académie des sciences. Série III, Sciences de la vie·M David-DufilhoM A Devynck
Jan 23, 2016·International Journal of Molecular Sciences·Rikang WangHeru Chen

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.